![](/img/cover-not-exists.png)
MLN8237 (ALISERTIB), An Investigational Aurora a Kinase Inhibitor, in Patients (PTS) with Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Breast Cancer (BRC), Head and Neck Squamous Cell Carcinoma (HNSCC), And Gastroesophageal Cancer (GE): Emerging Phase (PH) 2 Results
Melichar, B., Lee, P., Alvarez, R.H., Degardin, M., Bennouna, J., Schusterbauer, C., Zhang, B., Benaim, E., Rosen, P.Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)33020-9
Date:
September, 2012
File:
PDF, 64 KB
2012